Skip to main content
Top
Published in: Malaria Journal 1/2012

Open Access 01-10-2012 | Poster presentation

Improving LLIN utilization and coverage through an innovative distribution and malaria education model: a pilot study in Okavango Sub-District, Botswana

Authors: Simon Chihanga, Allison Tatarsky, HT Masendu, D Ntebela, Tjantilili Mosweunyane, Mpho Motlaleng, Godira Segoea, Justin M Cohen, Mercy Puso, Bosiela Segogo, Tshepo Andina

Published in: Malaria Journal | Special Issue 1/2012

Login to get access

Excerpt

The Botswana Malaria Indicator Survey in 2007 indicated remarkably low ITN coverage and usage rates of 9.4% and 5.3%, respectively. To achieve universal coverage of LLINs, optimize uptake, and catalyze Botswana toward its 2015 goal of elimination, Botswana tested a new delivery model to replace its revolving fund scheme of selling subsidized nets to communities at risk. …
Metadata
Title
Improving LLIN utilization and coverage through an innovative distribution and malaria education model: a pilot study in Okavango Sub-District, Botswana
Authors
Simon Chihanga
Allison Tatarsky
HT Masendu
D Ntebela
Tjantilili Mosweunyane
Mpho Motlaleng
Godira Segoea
Justin M Cohen
Mercy Puso
Bosiela Segogo
Tshepo Andina
Publication date
01-10-2012
Publisher
BioMed Central
Published in
Malaria Journal / Issue Special Issue 1/2012
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-11-S1-P95

Other articles of this Special Issue 1/2012

Malaria Journal 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine